157 related articles for article (PubMed ID: 36365110)
1. Evaluation of Adjuvant Activity and Bio-Distribution of Archaeosomes Prepared Using Microfluidic Technology.
Jia Y; Agbayani G; Chandan V; Iqbal U; Dudani R; Qian H; Jakubek Z; Chan K; Harrison B; Deschatelets L; Akache B; McCluskie MJ
Pharmaceutics; 2022 Oct; 14(11):. PubMed ID: 36365110
[TBL] [Abstract][Full Text] [Related]
2. The Synergistic Effects of Sulfated Lactosyl Archaeol Archaeosomes When Combined with Different Adjuvants in a Murine Model.
Jia Y; Akache B; Agbayani G; Chandan V; Dudani R; Harrison BA; Deschatelets L; Hemraz UD; Lam E; Régnier S; Stark FC; Krishnan L; McCluskie MJ
Pharmaceutics; 2021 Feb; 13(2):. PubMed ID: 33540932
[TBL] [Abstract][Full Text] [Related]
3. Assessment of stability of sulphated lactosyl archaeol archaeosomes for use as a vaccine adjuvant.
Jia Y; Chandan V; Akache B; Qian H; Jakubek ZJ; Vinogradov E; Dudani R; Harrison BA; Jamshidi MP; Stark FC; Deschatelets L; Sauvageau J; Williams D; Krishnan L; McCluskie MJ
J Liposome Res; 2021 Sep; 31(3):237-245. PubMed ID: 32583693
[TBL] [Abstract][Full Text] [Related]
4. A comparison of the immune responses induced by antigens in three different archaeosome-based vaccine formulations.
Jia Y; Akache B; Deschatelets L; Qian H; Dudani R; Harrison BA; Stark FC; Chandan V; Jamshidi MP; Krishnan L; McCluskie MJ
Int J Pharm; 2019 Apr; 561():187-196. PubMed ID: 30836154
[TBL] [Abstract][Full Text] [Related]
5. Mechanistic insight into the induction of cellular immune responses by encapsulated and admixed archaeosome-based vaccine formulations.
Agbayani G; Jia Y; Akache B; Chandan V; Iqbal U; Stark FC; Deschatelets L; Lam E; Hemraz UD; Régnier S; Krishnan L; McCluskie MJ
Hum Vaccin Immunother; 2020 Sep; 16(9):2183-2195. PubMed ID: 32755430
[TBL] [Abstract][Full Text] [Related]
6. Sulfated Lactosyl Archaeol Archaeosomes Synergize with Poly(I:C) to Enhance the Immunogenicity and Efficacy of a Synthetic Long Peptide-Based Vaccine in a Melanoma Tumor Model.
Akache B; Agbayani G; Stark FC; Jia Y; Dudani R; Harrison BA; Deschatelets L; Chandan V; Lam E; Hemraz UD; Régnier S; Krishnan L; McCluskie MJ
Pharmaceutics; 2021 Feb; 13(2):. PubMed ID: 33673382
[TBL] [Abstract][Full Text] [Related]
7. Generation of a Liposomal Vaccine Adjuvant Based on Sulfated S-Lactosylarchaeol (SLA) Glycolipids.
Akache B; Jia Y; Chandan V; Deschatelets L; McCluskie MJ
Methods Mol Biol; 2022; 2412():255-267. PubMed ID: 34918249
[TBL] [Abstract][Full Text] [Related]
8. Safety and biodistribution of sulfated archaeal glycolipid archaeosomes as vaccine adjuvants.
Akache B; Stark FC; Iqbal U; Chen W; Jia Y; Krishnan L; McCluskie MJ
Hum Vaccin Immunother; 2018 Jul; 14(7):1746-1759. PubMed ID: 29336668
[TBL] [Abstract][Full Text] [Related]
9. In vitro evaluation of archaeosome vehicles for transdermal vaccine delivery.
Jia Y; McCluskie MJ; Zhang D; Monette R; Iqbal U; Moreno M; Sauvageau J; Williams D; Deschatelets L; Jakubek ZJ; Krishnan L
J Liposome Res; 2018 Dec; 28(4):305-314. PubMed ID: 28948854
[TBL] [Abstract][Full Text] [Related]
10. Sulfated archaeal glycolipid archaeosomes as a safe and effective vaccine adjuvant for induction of cell-mediated immunity.
McCluskie MJ; Deschatelets L; Krishnan L
Hum Vaccin Immunother; 2017 Dec; 13(12):2772-2779. PubMed ID: 28537465
[TBL] [Abstract][Full Text] [Related]
11. Effect of Chiral Purity on Adjuvanticity of Archaeol-Based Glycolipids.
Régnier S; Lam E; Vasquez V; Martinez-Farina CF; Stark FC; Agbayani G; Deschatelets L; Dudani R; Harrison BA; Akache B; McCluskie MJ; Hemraz UD
J Med Chem; 2022 Jun; 65(12):8332-8344. PubMed ID: 35658102
[TBL] [Abstract][Full Text] [Related]
12. Simplified Admix Archaeal Glycolipid Adjuvanted Vaccine and Checkpoint Inhibitor Therapy Combination Enhances Protection from Murine Melanoma.
Stark FC; Agbayani G; Sandhu JK; Akache B; McPherson C; Deschatelets L; Dudani R; Hewitt M; Jia Y; Krishnan L; McCluskie MJ
Biomedicines; 2019 Nov; 7(4):. PubMed ID: 31771150
[TBL] [Abstract][Full Text] [Related]
13. Sulfated archaeol glycolipids: Comparison with other immunological adjuvants in mice.
Akache B; Stark FC; Jia Y; Deschatelets L; Dudani R; Harrison BA; Agbayani G; Williams D; Jamshidi MP; Krishnan L; McCluskie MJ
PLoS One; 2018; 13(12):e0208067. PubMed ID: 30513093
[TBL] [Abstract][Full Text] [Related]
14. Phosphatidylserine receptor-mediated recognition of archaeosome adjuvant promotes endocytosis and MHC class I cross-presentation of the entrapped antigen by phagosome-to-cytosol transport and classical processing.
Gurnani K; Kennedy J; Sad S; Sprott GD; Krishnan L
J Immunol; 2004 Jul; 173(1):566-78. PubMed ID: 15210818
[TBL] [Abstract][Full Text] [Related]
15. Safety of archaeosome adjuvants evaluated in a mouse model.
Patel GB; Omri A; Deschatelets L; Sprott GD
J Liposome Res; 2002 Nov; 12(4):353-72. PubMed ID: 12519630
[TBL] [Abstract][Full Text] [Related]
16. Archaeosomes varying in lipid composition differ in receptor-mediated endocytosis and differentially adjuvant immune responses to entrapped antigen.
Sprott GD; Sad S; Fleming LP; Dicaire CJ; Patel GB; Krishnan L
Archaea; 2003 Oct; 1(3):151-64. PubMed ID: 15803661
[TBL] [Abstract][Full Text] [Related]
17. Influence of coenzyme Q10 on tissue distribution of archaeosomes, and pegylated archaeosomes, administered to mice by oral and intravenous routes.
Omri A; Makabi-Panzu B; Agnew BJ; Sprott GD; Patel GB
J Drug Target; 2000; 7(5):383-92. PubMed ID: 10721800
[TBL] [Abstract][Full Text] [Related]
18. Sulfated Lactosyl Archaeol Archaeosome-Adjuvanted Vaccine Formulations Targeting Rabbit Hemorrhagic Disease Virus Are Immunogenic and Efficacious.
Akache B; Read AJ; Dudani R; Harrison BA; Williams D; Deschatelets L; Jia Y; Chandan V; Stark FC; Agbayani G; Makinen SR; Hemraz UD; Lam E; Régnier S; Zou W; Kirkland PD; McCluskie MJ
Vaccines (Basel); 2023 May; 11(6):. PubMed ID: 37376432
[TBL] [Abstract][Full Text] [Related]
19. Archaeosomes induce long-term CD8+ cytotoxic T cell response to entrapped soluble protein by the exogenous cytosolic pathway, in the absence of CD4+ T cell help.
Krishnan L; Sad S; Patel GB; Sprott GD
J Immunol; 2000 Nov; 165(9):5177-85. PubMed ID: 11046050
[TBL] [Abstract][Full Text] [Related]
20. Archaeosomes as self-adjuvanting delivery systems for cancer vaccines.
Krishnan L; Dennis Sprott G;
J Drug Target; 2003; 11(8-10):515-24. PubMed ID: 15203920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
